Nurse Practitioner in Peshtigo, WI Accepting Medicare

4 Nurse Practitioner nurses found. Showing 1 - 4

Mrs. Rhonda Lynn Cumicek, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 441 French St, Peshtigo, WI 54157 Phone: 715-582-9949    Fax: 715-582-4464

Kate S Laurin, APNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 603 French St, Peshtigo, WI 54157 Phone: 715-582-3622

Ramona S Klevgard, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 501 N Lake St, Peshtigo, WI 54157 Phone: 715-582-3906    Fax: 715-582-3141

Carol L Orwig, FNPC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 441 French St, Peshtigo, WI 54157 Phone: 715-582-9949    Fax: 715-582-4464

News Archive

CellCentric out-licenses development, commercialisation of novel epigenetic discovery programme to Takeda Pharmaceutical

From its broad portfolio of novel targets in epigenetics, CellCentric has out-licensed exclusively the development and commercialisation of an important programme focused on cancer.

Simple rectal swab cultures can thwart drug-resistant E. coli in patients undergoing TRUSBx procedures

Some infections after prostate biopsy due to drug-resistant Escherichia coli can be thwarted by simple rectal swab cultures prior to the procedure. The cultures test for antibiotic-resistant E. coli, and the findings are used to direct the selection of antimicrobial prophylaxis used for the procedure, according to Rhode Island Hospital researchers.

Scooter madness in Austin puts safety concerns in high gear

University of Texas star baseball shortstop David Hamilton hit a pothole riding an electric scooter, tearing his Achilles tendon and requiring surgery. He'll miss the season. Cristal Glangchai, the CEO for a nonprofit, hit a rock riding her scooter, landing her on the pavement just blocks from home.

Gilead sues Lupin over Ranexa patent infringement

Gilead Sciences, Inc. today announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa® (ranolazine extended-release tablets). The lawsuit is based on an Abbreviated New Drug Application filed by Lupin, which seeks approval to manufacture and market a generic version of Ranexa before the expiration of Gilead's Ranexa patents.

Key method to test compounds for anti-cancer activity in cells flawed, study reveals

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers report May 2 in Nature Methods. The findings cast doubt on methods used by the entire scientific enterprise and pharmaceutical industry to discover new cancer drugs.

Read more Medical News

› Verified 6 days ago